BiotechTube
Home/Coya Therapeutics/Dr. Howard Berman
DH

Dr. Howard Berman

Executive Chairman of the Board

Coya Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesAutoimmune DisordersMetabolic Diseases

Coya Therapeutics Pipeline

DrugIndicationPhase
COYA 302Amyotrophic Lateral Sclerosis (ALS)Phase 2
COYA 201Undisclosed Inflammatory IndicationsPreclinical
COYA 101Undisclosed Autoimmune IndicationsPreclinical

Leadership Team at Coya Therapeutics

DS
Dr. Stanley H. Appel
Co-founder and Chairman Emeritus
DA
Dr. Arun Swaminathan
Chief Executive Officer
DF
Dr. Fred Grossman
Chief Medical Officer
AM
Ann Maurer
Chief Financial Officer
View full Coya Therapeutics profile